All Type of News
Health insurance coverage of endoscopic submucosal dissection to be expanded
The Health Insurance Review and Assessment Service plans to announce its revision of government guidelines on endoscopic surgery in treating gastric cancer, aiming to expand the health insurance coverage through its s...
Dong-A to launch biosimilar plant in Songdo
Dong-A Pharmaceutical Co., the nation’s No.1 drug maker, said Thursday that it signed a memorandum of understanding (MOU) with Incheon Free Economic Zone (IFEZ) Authority to build and operate a a global biomedicine co...
Drug distribution cooperatives to select potential bidders
The committee for the projected drug distribution cooperatives will hold a business information session at Seoul Saint Mary’s Hospital.
The session, which will be held at 2 p.m. on October 11, is expected to attrac...
May GNP leader has initiatives to push for opposition on revision of pharmaceutical affairs law?
The opposition by a top right-wing politician over a bill to revise the Pharmaceutical Affairs Law, designed to allow the sale of painkillers and cold medicines at convenience stores, is drawing attention as he is one...
Revision of pharmaceutical affairs law unlikely to pass Assembly
A bill to revise the Pharmaceutical Affairs Law, approved at the Cabinet meeting Tuesday, is facing opposition from lawmakers, with the prospect of the relevant bill passing the National Assembly appearing dim.
The...
Government, drugmakers poles apart on drug price reform
The government and domestic drug firms remain far apart in their positions over the latter’s plan to cut drug prices by an average of 17 percent starting next year, which has triggered vehement protests from the domes...
Competition getting stiff for DPP-4 inhibitors
Following Bristol-Myers Squibb’s Onglyza (saxagliptin), Boehringer Ingelheim finally won the approval of the Korea Food and Drug Administration for their diabetes drug Trajenta (linagliptin), a dipeptidyl peptidase 4 ...
Court rejects drug price cuts lodged by health ministry
A court granted Tuesday Dong-A’s and Chong Kun Dang’s request for a preliminary injunction to suspend the improper reduction of insurance drug prices filed by the Ministry of Health and Welfare.
The ministry filed ...
Tension remains over OTC drug sales
Pharmacists are still alerting over the possible backlash from customers and various interest groups claiming the sales of additional over-the-counter (OTC) drugs in supermarkets, although the Cabinet’s recent approva...
Korean firms shy of R&D
Korean drug firms are showing a negative attitude towards research and development (R&D) due to the government’s plan to cut drug prices by an average of 17 percent starting next year, according to Rep. Choi Young-hee...
